Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022

SELL
$33.11 - $55.01 $1.22 Million - $2.02 Million
-36,749 Closed
0 $0
Q3 2020

Oct 28, 2020

BUY
$81.91 - $134.94 $1.17 Million - $1.93 Million
14,282 Added 63.57%
36,749 $3.8 Million
Q1 2020

Apr 21, 2020

BUY
$49.34 - $68.76 $1.11 Million - $1.54 Million
22,467 New
22,467 $1.3 Million
Q2 2019

Jul 10, 2019

SELL
$39.92 - $53.86 $8,103 - $10,933
-203 Closed
0 $0
Q4 2018

Jan 15, 2019

SELL
$55.63 - $73.24 $11,348 - $14,940
-204 Reduced 50.12%
203 $12,000
Q3 2017

Oct 13, 2017

BUY
$34.14 - $40.45 $13,894 - $16,463
407
407 $16,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $465M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Dubuque Bank & Trust CO Portfolio

Follow Dubuque Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dubuque Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Dubuque Bank & Trust CO with notifications on news.